Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses —— — Research & development —— — Operating income 23.69 M22.28 M — Non-Operating Income, Total 31 K137 K — Interest expense, net of interest capitalized 0300 K — Non-Operating Income, excl. Interest Expenses 0-300 K — Unusual income/expense 31 K137 K — Pretax income 4.39 M-14.37 M — Equity in earnings —— — Taxes -366 K-788 K — Non-controlling/minority interest -2.17 M-11.88 M — After tax other income/expense —— — Net income before discontinued operations -667 K-4.54 M — Discontinued operations —— — Net income -667 K-4.54 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -667 K-4.54 M — Basic earnings per share (Basic EPS) -0.02-0.1 — Diluted earnings per share (Diluted EPS) -0.02-0.1 — Average basic shares outstanding 43.26 M43.26 M — Diluted shares outstanding 43.26 M43.26 M — EBITDA 38.82 M62.96 M — EBIT 15.52 M19.86 M — Cost of revenue 88.25 M162.05 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 23.3 M43.1 M —